NO138376C - Fremgangsmaate for fremstilling av 1-beta-d-ribofuranosyl-1, 2, 4-triazol-3-karboksamid - Google Patents

Fremgangsmaate for fremstilling av 1-beta-d-ribofuranosyl-1, 2, 4-triazol-3-karboksamid

Info

Publication number
NO138376C
NO138376C NO740841A NO740841A NO138376C NO 138376 C NO138376 C NO 138376C NO 740841 A NO740841 A NO 740841A NO 740841 A NO740841 A NO 740841A NO 138376 C NO138376 C NO 138376C
Authority
NO
Norway
Prior art keywords
ribofuranosyl
carboxamide
triazole
beta
preparing
Prior art date
Application number
NO740841A
Other languages
English (en)
Norwegian (no)
Other versions
NO138376B (no
NO740841L (no
Inventor
Joseph Theodore Witkowski
Roland Kenith Robins
Original Assignee
Icn Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US340332A external-priority patent/US3927216A/en
Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals
Publication of NO740841L publication Critical patent/NO740841L/no
Publication of NO138376B publication Critical patent/NO138376B/no
Publication of NO138376C publication Critical patent/NO138376C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056Triazole or tetrazole radicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
NO740841A 1973-03-12 1974-03-11 Fremgangsmaate for fremstilling av 1-beta-d-ribofuranosyl-1, 2, 4-triazol-3-karboksamid NO138376C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US340332A US3927216A (en) 1971-06-01 1973-03-12 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections

Publications (3)

Publication Number Publication Date
NO740841L NO740841L (no) 1974-09-13
NO138376B NO138376B (no) 1978-05-16
NO138376C true NO138376C (no) 1978-08-23

Family

ID=23332899

Family Applications (1)

Application Number Title Priority Date Filing Date
NO740841A NO138376C (no) 1973-03-12 1974-03-11 Fremgangsmaate for fremstilling av 1-beta-d-ribofuranosyl-1, 2, 4-triazol-3-karboksamid

Country Status (15)

Country Link
JP (2) JPS5836960B2 (es)
AR (1) AR205339A1 (es)
BE (2) BE812191A (es)
CH (1) CH602785A5 (es)
DE (1) DE2411823A1 (es)
ES (1) ES424201A1 (es)
FR (2) FR2221138B1 (es)
GB (1) GB1427304A (es)
IE (1) IE38987B1 (es)
IL (2) IL44394A0 (es)
LU (1) LU69626A1 (es)
NL (1) NL7403289A (es)
NO (1) NO138376C (es)
PH (1) PH12043A (es)
ZA (1) ZA741610B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2940654A1 (de) * 1979-10-06 1981-04-16 Bayer Ag, 5090 Leverkusen Dimeres keten der 1,2,,-triazol-3-carbonsaeure
EP0034481B1 (en) * 1980-02-14 1984-05-30 Grigg, Ronald Ernest 2-methyl-5-thiazole-methylamine and carboxamide derivatives
FI70425C (fi) * 1980-04-23 1986-09-19 Wellcome Found Foerfarande foer framstaellning av 4-substituerade 1-beta-ribofuranosyl-1h-imidazo/4,5-c/pyridiner
JPS57146593A (en) * 1981-03-09 1982-09-10 Ajinomoto Co Inc Preparation of ribofuranosyltriazole derivative
BE902199A (fr) * 1984-10-29 1985-07-31 Vira Tek Inc Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1, 2,4-triazole-3-carboxamide.
JPS62165096A (ja) * 1986-01-14 1987-07-21 Hitachi Ltd 給油装置
JPWO2009028575A1 (ja) 2007-08-27 2010-12-02 国立大学法人名古屋大学 血液凝固第vii因子プロモーターの活性化剤及びその利用
WO2009028573A1 (ja) 2007-08-27 2009-03-05 National University Corporation Nagoya University 血液凝固障害におけるリバビリンの利用

Also Published As

Publication number Publication date
ES424201A1 (es) 1976-05-01
FR2289520B1 (es) 1978-05-12
LU69626A1 (es) 1974-08-06
BE812191A (fr) 1974-07-01
JPS5836960B2 (ja) 1983-08-12
FR2289520A1 (fr) 1976-05-28
GB1427304A (en) 1976-03-10
FR2221138B1 (es) 1978-07-28
ZA741610B (en) 1975-02-26
NL7403289A (es) 1974-09-16
AU6670874A (en) 1975-09-18
PH12043A (en) 1978-10-18
JPS5029720A (es) 1975-03-25
FR2221138A1 (es) 1974-10-11
IE38987L (en) 1974-09-12
NO138376B (no) 1978-05-16
IL44394A0 (en) 1974-06-30
AR205339A1 (es) 1976-04-30
JPS58219115A (ja) 1983-12-20
NO740841L (no) 1974-09-13
DE2411823A1 (de) 1974-09-26
IL52848A0 (en) 1977-10-31
CH602785A5 (es) 1978-08-15
BE903675Q (fr) 1986-05-20
JPS5915886B2 (ja) 1984-04-12
IE38987B1 (en) 1978-07-05

Similar Documents

Publication Publication Date Title
SE419981B (sv) Forfarande for framstellning av 1alfa-hydroxi-vitamin d-derivat
SE7506819L (sv) Forfarande for framstellning av substituerade 1,2,4-triazolderivat
SE453667B (sv) Forfarande for framstellning av polyeterimider
SE412389B (sv) Forfarande for framstellning av 1-ftalazon-derivat.
SE435713B (sv) Forfarande for framstellning av 1,3-bensoxazoler
SE419750B (sv) Forfarande for framstellning av 6-acyl-2,4-dialkyl-2-hydroxicyklohexan-1,35-trion
SE420720B (sv) Forfarande for framstellning av 2,6-disubstuerade fenylaminoguanidinforeningar
AR202653A1 (es) Preparacion de 2,2,6,6-tetrametil-4-oxopiperidina
SE429237B (sv) Forfarande for framstellning av 9,3",4"-tri-alkanoyl sf-837 m,-derivat
NO740320L (no) Fremgangsmåte for fremstilling 6-deoksyoksytetracyklin.
NO138376C (no) Fremgangsmaate for fremstilling av 1-beta-d-ribofuranosyl-1, 2, 4-triazol-3-karboksamid
SE416053B (sv) Forfarande for framstellning av 7alfa-metylostr-4-en-3alfa, 17beta-diol
SE421129B (sv) Forfarande for framstellning av poly-n-alkyl-iminoalaner
SE431451B (sv) Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
SE402105B (sv) Forfarande for framstellning av 2-amino-5-alkyl-1,3,4-tiadiazoler
SE410458B (sv) Forfarande for framstellning av vissa angivna 1,2,4-triazolderivat
SE412226B (sv) Forfarande for framstellning av 2,2',3,3-tetrakarboxidifenyleterdianhydrid
SE405119B (sv) Forfarande for framstellning av 2,4-diamino-5-bensyl-pyrimidiner
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
SE419980B (sv) Forfarande for framstellning av eventuellt substituerade 2-fenyl-bicyklo /2,2,2/okt-3-ylalkylaminer
SE401833B (sv) Forfarande for framstellnig av vissa angivna 1,2,4-friazolderivat
SE419445B (sv) Analogiforfarande for framstellning av 1,4-bensodiazepinderivat
SE418084B (sv) Forfarande for framstellning av 1,2,4-bensotiadiazin-derivat
TR18199A (tr) Yeni 3, 4-dihidro-1, 2, 4-triazinlerin hazirlanmasina mahsus usul
NO138146C (no) Fremgangsmaate for fremstilling av 2,2`-anhydro-1beta-d-arabinfuranosyl-5-cytosin